Le Lézard
Classified in: Health, Science and technology
Subject: Webcast

Cyteir Therapeutics to Host Virtual Research and Development (R&D) Day on April 26, 2022


Cyteir Therapeutics, Inc. ("Cyteir") (Nasdaq: CYT), a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer, will host a virtual R&D Day on April 26, 2022 starting at 8:30 a.m. ET. Cyteir's management will discuss the research done to identify the molecular target of CYT-0851 and review the ongoing clinical plan.

The live audio webcast can be accessed via the Investor Relations section of the Company's website at www.cyteir.com. The archived webcast will remain available for replay on Cyteir's website for 30 days.

About Cyteir Therapeutics, Inc.

Cyteir is a clinical-stage oncology company that is focused on the discovery and development of next-generation synthetically lethal therapies to treat cancer. The company is using its expertise in DNA damage response biology to advance a pipeline of novel drug candidates that selectively target key cancer vulnerabilities. Cyteir's wholly owned lead compound, CYT-0851, is a potent and selective, oral investigational drug currently in a Phase 1/2 clinical trial for hematologic and solid tumors. Follow Cyteir on social media: LinkedIn and Twitter.


These press releases may also interest you

at 11:10
Reperio Health, the only provider of at-home and onsite comprehensive health screenings with instant results, announced today that they have been selected as the exclusive biometric health screening partner for The Partners Group (TPG), a leading...

at 11:09
High Bandwidth Memory (HBM) Market is Segmented by Type (HBM2, HBM2E, HBM3, HBM3E, Others), by Application (Servers, Networking, Consumer, Others): Global Opportunity Analysis and Industry Forecast, 2024-2030. It is Published in Valuates...

at 11:08
Nooks, the fastest-growing AI dialing & prospecting platform, announced today that it has raised $22M in Series A funding. The round was led by Lachy Groom with participation from Tola Capital and Stifel Venture Banking, bringing Nooks...

at 11:05
CloudBees, Inc., your strategic partner in cloud transformation journey, today announced that Bryan Palma, CEO at Trellix, has been appointed to its board of directors. Bryan joins existing independent board members Lynne Doherty, president at Sumo...

at 11:05
LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, announced its consolidated results today for the fourth quarter and full year ended March 31, 2024, as approved by its Board of Directors. "We...

at 11:05
Vanilla, a leading provider of innovative estate planning software, today announced an expanded set of features for Vanilla Document BuilderTM, the modern document creation engine within the Vanilla Estate Advisory Platform. Financial advisors using...



News published on and distributed by: